Copyright
©The Author(s) 2019.
World J Gastrointest Oncol. Nov 15, 2019; 11(11): 1065-1080
Published online Nov 15, 2019. doi: 10.4251/wjgo.v11.i11.1065
Published online Nov 15, 2019. doi: 10.4251/wjgo.v11.i11.1065
SNP | Location | Primer sequence |
BAT26 | 2p16 | p1 TGACTACTTTTGACTTCAGCC |
p2 AACCATTCAACATTTTTAACCC | ||
D2S123 | 2p21-2p16 | p1 AAACAGGATGCCTGCCTTTA |
p2 GGACTTTCCACCTATGGGAC | ||
D5S346 | 5q21-5q22 | p1 ACTCACTCTAGTGATAAATCGGG |
p2 CAGATAAGACAGTATTACTAGTT | ||
BAT25 | 4q12 | p1 TCGCCTCCAAGAATGTAAGT |
p2 TCTGCATTTTAACTATGGCTC | ||
D17S250 | 17q11.2-17q12 | p1 GGAAGAATCAAATAGACAAT |
p2 GCTGGCCATATATATATTTAAACC |
- Citation: Wang SM, Jiang B, Deng Y, Huang SL, Fang MZ, Wang Y. Clinical significance of MLH1/MSH2 for stage II/III sporadic colorectal cancer. World J Gastrointest Oncol 2019; 11(11): 1065-1080
- URL: https://www.wjgnet.com/1948-5204/full/v11/i11/1065.htm
- DOI: https://dx.doi.org/10.4251/wjgo.v11.i11.1065